Andreas Krause

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

Jürgen Braun, J. Brandt, Joachim Listing et al. · The Lancet · 2002 · 1.3K citations

Medicine, Clinical Sciences, Internal Medicine +7

Evaluation of the RABBIT Risk Score for serious infections

A. Zink, Bernhard Manger, Jörg Kaufmann et al. · Annals of the Rheumatic Diseases · 2013 · 140 citations · Full text

Medicine, Immunology, Internal Medicine +16

Persistent clinical efficacy and safety of infliximab in ankylosing spondylitis after 8 years--early clinical response predicts long-term outcome

Xenofon Baraliakos, Joachim Listing, C. Fritz et al. · Lara D. Veeken · 2011 · 117 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice

Vivian P. Bykerk, Andrew J.K. Östör, José María Álvaro‐Gracia et al. · Annals of the Rheumatic Diseases · 2012 · 115 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis.

A. Zink, K. Thiele, Dörte Huscher et al. · PubMed · 2006 · 110 citations

Medicine, Clinical Sciences, Internal Medicine +16